Obermatt
See Similar Stocks →

Diagnósticos da América

SAO:DASA3 · BRDASAACNOR1
Health Care Providers & ServicesMedium

360

51
EV / EBIT89
Price / Owner Earnings68
Owner Earnings Yield1
Dividend Yield49
Price/Sales93
EV / Gross Profit60
Price/Book93
Return on Capital48
Cash Return on Capital26
Return on Equity22
EBIT Margin74
Gross Profitability17
Accruals85
Owner Earnings Margin22
Sales growth1
Profit Growth53
Long-Term EPS Growth98
Reinvestment43
Price momentum95
Debt load11
Refinancing95
Debt Payback1
Liquidity6
Analyst ratings23
Opinion Changes80
Price Target Upside75
Market mood48
Value Creation2/20not creating value
  • Creates more value than its capital costs
  • Owner earnings growing
  • Owner earnings per share growing
  • Reinvests at strong returns
  • Solid earnings base

What this means

Diagnósticos da América doesn't consistently earn more than its cost of capital, so it isn't yet creating shareholder value.

Profile

CountryBrazil
IndustryHealth Care Providers & Services
SizeMedium
TypePublic Company
ExchangeBOVESPA
Founded1966
Employees886
Websitedasa.com.br
ISINBRDASAACNOR1
Last UpdateApr 2, 2026
Index & Theme
Chronic DiseasesPredictive AnalyticsGeneticsOncologyHealth DiagnosticsClinical TrialsHealth CareMedicalProduct Research

Description

Diagnósticos da América S.A., together with its subsidiaries, provides diagnostic and hospital services. Business Segments The company operates through three segments: Hospitals and Oncology, Diagnostics and Care Coordination, and International Dia…

Analysis

Middle-of-the-road

Diagnósticos da América S.A. is a middle-of-the-road business: neither the economics nor the price stand out from the peer group.

Valuation data is not available for this company.

The trajectory is solid and the balance sheet is stretched. The company scores 2/20 on our value-creation score: not creating value.

What to watch: The financial cushion is thinner than comfortable. As always: this describes the company's numbers; it is not a recommendation.

360° rank · history

1007550250
57
2023202420252026

All-time high

57

Jun 2026

All-time low

8

Jan 2024

Average rank

28

across all years

Detailed & Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history.

Current202520242023
Price/Sales
93
100
100
91
Price/Earnings
80
95
65
69
Price/Book
93
97
85
73
Dividend Yield
49
67
44
60
Value (overall)
91
83
80
81

Cells are coloured by rank band (red weak → green strong). Sentiment & 360° history begins 2023.

Similar Stocks

The companies this stock is ranked against.

Compare Diagnósticos da América with its peers
Fleury
SAO:FLRY3
95
CountryBrazil
IndustryHealth Care Providers & Services
SizeLarge
Full Stock Analysis →
Hapvida Participações e Investimentos
SAO:HAPV3
22
CountryBrazil
IndustryHealth Care Providers & Services
SizeLarge
Full Stock Analysis →
Dr. Lal PathLabs
NSI:LALPATHLAB
62
CountryIndia
IndustryHealth Care Providers & Services
SizeMedium
Full Stock Analysis →
IHH Healthcare
KLS:IHH
36
CountryMalaysia
IndustryHealth Care Providers & Services
SizeX-Large
Full Stock Analysis →
Life Healthcare Group
JNB:LHC
100
CountrySouth Africa
IndustryHealth Care Providers & Services
SizeLarge
Full Stock Analysis →
Max Healthcare Institute
NSI:MAXHEALTH
58
CountryIndia
IndustryHealth Care Providers & Services
SizeLarge
Full Stock Analysis →

Make Sense of the Ranks

Every rank runs 1–100 against true peers. Higher is always better.

360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100
Learn More →